[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on […]

[11-08-2024] The Food and Drug Administration is advising consumers not to purchase or use  VITAFER-L Gold 500ml, a product promoted for energy and sexual enhancement on […]

On November 8, 2024, the Food and Drug Administration approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-directed genetically modified autologous T cell immunotherapy, for adults with […]

For Immediate Release: November 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

COMMITTEE’S OFFICIAL DESIGNATION Drug Safety and Risk Management Advisory Committee AUTHORITY The Drug Safety and Risk Management Advisory Committee (the Committee) is established under 15 U.S.C. […]

Recruitment and hiring events No matter your field of study or professional background, you can be a part of the workforce that’s protecting the health and […]

On This Page Date: December 4, 2024 Time: 8:00 AM – 3:00 PM ET Location: Event Location FDA HeadquartersFDA headquarters in White Oak, MD 10903 New […]

The following pages contain safety, regulatory and availability information. For information on specific drugs, please see the Index to Drug-Specific Information. What’s New Resources Content current […]

FDA and representatives of the generic drug industry meet bi-annually to discuss current and emerging regulatory science challenges and concerns. Minutes from these meetings are posted […]